Joseph Fraietta

Person

Cherry Hill, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
- Patent number 10,357,514
- Issue date Jul 23, 2019
- The Trustees of the University of Pennsylvania
- Carl H. June
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
OPTIMIZING T CELL DIFFERENTIATION STATE WITH MICRORNAS
- Publication number 20240342280
- Publication date Oct 17, 2024
- The Trustees of the University of Pennsylvania
- Erietta Stelekati
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS COMPRISING CAR T CELLS COMPRISING PRDM1 AN...
- Publication number 20240325535
- Publication date Oct 3, 2024
- The Trustees of the University of Pennsylvania
- Joseph A. Fraietta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAR T CELL THERAPIES WITH ENHANCED EFFICACY
- Publication number 20240076372
- Publication date Mar 7, 2024
- Novartis AG
- Christopher Loren Nobles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CAR T CELL THERAPIES WITH ENHANCED EFFICACY
- Publication number 20230139800
- Publication date May 4, 2023
- Novartis AG
- Gregory Motz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BIOMARKERS FOR EVALUATING CAR-T CELLS TO PREDICT CLINICAL OUTCOME
- Publication number 20210396739
- Publication date Dec 23, 2021
- Novartis AG
- Iulian Pruteanu-Malinici
- G01 - MEASURING TESTING
Information Patent Application
CAR T CELL THERAPIES WITH ENHANCED EFFICACY
- Publication number 20210047405
- Publication date Feb 18, 2021
- Novartis AG
- Christopher Loren Nobles
- G01 - MEASURING TESTING
Information Patent Application
BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR, AND USES THEREOF
- Publication number 20200371091
- Publication date Nov 26, 2020
- Novartis AG
- Iulian Pruteanu-Malinici
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
- Publication number 20200370012
- Publication date Nov 26, 2020
- Novartis AG
- Joseph A. Fraietta
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOMARKERS AND CAR T CELL THERAPIES WITH ENHANCED EFFICACY
- Publication number 20200087376
- Publication date Mar 19, 2020
- The Trustees of the University of Pennsylvania
- Joseph A. Fraietta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190388471
- Publication date Dec 26, 2019
- Novartis AG
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAR T CELL THERAPIES WITH ENHANCED EFFICACY
- Publication number 20180258149
- Publication date Sep 13, 2018
- Novartis AG
- Gregory Motz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDI...
- Publication number 20180140602
- Publication date May 24, 2018
- Novartis AG
- Daniela Angst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20150283178
- Publication date Oct 8, 2015
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Joseph Fraietta

Person

Patents Grantslast 30 patents

Treatment of cancer using anti-CD19 Chimeric Antigen Receptor

Patents Applicationslast 30 patents

OPTIMIZING T CELL DIFFERENTIATION STATE WITH MICRORNAS

COMPOSITIONS AND METHODS COMPRISING CAR T CELLS COMPRISING PRDM1 AN...

CAR T CELL THERAPIES WITH ENHANCED EFFICACY

CAR T CELL THERAPIES WITH ENHANCED EFFICACY

BIOMARKERS FOR EVALUATING CAR-T CELLS TO PREDICT CLINICAL OUTCOME

CAR T CELL THERAPIES WITH ENHANCED EFFICACY

BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR, AND USES THEREOF

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

BIOMARKERS AND CAR T CELL THERAPIES WITH ENHANCED EFFICACY

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

CAR T CELL THERAPIES WITH ENHANCED EFFICACY

COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDI...

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR